Opus Genetics, Inc.
IRD
$0.865
$0.00430.50%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 30.32M | 36.64M | 41.41M | 47.17M | 50.52M |
Total Receivables | 5.77M | 3.33M | 2.31M | 3.12M | 2.33M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 515.00K | 343.00K | 1.03M | 1.47M | 1.10M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | 86.00K | 87.00K | 89.00K | -- |
Total Current Assets | 36.61M | 40.39M | 44.83M | 51.84M | 53.95M |
|
|||||
Total Current Assets | 36.61M | 40.39M | 44.83M | 51.84M | 53.95M |
Net Property, Plant & Equipment | 252.00K | 0.00 | 0.00 | 0.00 | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 36.86M | 40.39M | 44.83M | 51.84M | 53.95M |
|
|||||
Total Accounts Payable | 3.15M | 844.00K | 634.00K | 2.06M | 2.15M |
Total Accrued Expenses | 8.15M | 5.17M | 3.49M | 3.65M | 1.82M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 2.00K | 74.00K | 74.00K | 74.00K | 74.00K |
Total Other Current Liabilities | 2.00K | 74.00K | 74.00K | 74.00K | 74.00K |
Total Current Liabilities | 11.30M | 6.09M | 4.20M | 5.79M | 4.04M |
|
|||||
Total Current Liabilities | 11.30M | 6.09M | 4.20M | 5.79M | 4.04M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 11.30M | 6.09M | 4.20M | 5.79M | 4.04M |
|
|||||
Common Stock & APIC | 145.72M | 138.16M | 136.97M | 134.63M | 131.37M |
Retained Earnings | -139.00M | -103.86M | -96.34M | -88.57M | -81.47M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 6.72M | 34.30M | 40.64M | 46.06M | 49.91M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 18.84M | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 18.84M | -- | -- | -- | -- |
|
|||||
Total Common Equity | 6.72M | 34.30M | 40.64M | 46.06M | 49.91M |
Total Preferred Equity | 18.84M | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 25.57M | 34.30M | 40.64M | 46.06M | 49.91M |
|